Supplementing neonatal piglets with bovine milk fat globule membrane (MFGM) in the first week of life enriches short-chain-fatty-acid (SCFA)-producing gut taxa, raises colonic SCFA, upregulates intestinal barrier genes, and improves growth to day 21, but the evidence is correlational. The open problem is the mechanistic decomposition of this effect: (i) which molecular component(s) of MFGM (gangliosides and other sphingolipids, MFG-E8/lactadherin, butyrophilin, fatty-acid-binding proteins, or defined glycoprotein/lipid moieties) causally drive the enrichment of SCFA-producing taxa and the barrier improvement; and (ii) whether the barrier improvement is causally mediated by the chain taxon enrichment -> increased luminal SCFA -> barrier-gene upregulation, or instead arises from direct effects of MFGM on the intestinal epithelium. Later literature has replicated the whole-MFGM phenotype in piglets and infants, provided in vitro digestion-fermentation evidence that whole digested MFGM can act as a fermentation substrate and cell-line evidence of a microbiota-independent epithelial signaling route, and demonstrated microbiota-to-SCFA causal mediation only in an adjacent maternal-fetal context; as of 2026 no study has isolated MFGM fractions or perturbed the proposed mediation chain in the neonatal intestine, and 2025-2026 reviews explicitly identify this mechanistic decomposition as an open gap.

Background

The milk fat globule membrane (MFGM) is the tri-layer membrane that surrounds fat globules secreted into milk; it is rich in phospholipids, sphingolipids (including gangliosides, a class of sialylated glycosphingolipids), and membrane glycoproteins such as butyrophilin, MFG-E8 (also called lactadherin, a milk glycoprotein involved in epithelial repair and immune regulation), and fatty-acid-binding proteins (FABPs, intracellular lipid chaperones also found in the MFGM fraction). MFGM is largely removed from infant formula by standard dairy processing, which motivated trials of MFGM-supplemented formula. Short-chain fatty acids (SCFAs) — mainly acetate, propionate, and butyrate — are bacterial fermentation products of nondigestible substrates in the gut lumen; butyrate is a principal fuel for colonocytes, and SCFAs signal through G-protein-coupled receptors such as GPR41/FFAR3 and GPR43/FFAR2 (free fatty-acid receptors on intestinal epithelial and immune cells) to influence epithelial tight junctions, the protein complexes (e.g., zonula occludens-1 (ZO-1), occludin, and claudins) that seal the paracellular space and constitute the intestinal barrier. Wu et al. (2021) gave neonatal piglets oral MFGM (1 g/kg body weight, days 1-7 of life) and, at day 21, found by 16S rRNA gene sequencing (a marker-gene survey of gut microbial composition) an enrichment of SCFA-producing taxa, higher colonic SCFA concentrations, upregulation of barrier genes measured by quantitative real-time PCR (qPCR, an assay quantifying messenger-RNA abundance of specific genes), and better growth. The authors themselves framed the result cautiously: they reported pairwise positive correlations between beneficial microbes, SCFA levels, and barrier-gene expression, and suggested that MFGM components such as gangliosides and MFG-E8 'might' directly promote barrier function. The study design (16 piglets, two groups, one dose, a single early administration window, endpoint at day 21) could not distinguish which MFGM component was active, nor whether the microbiota and its SCFA production were a cause of the barrier improvement rather than a correlated companion of it. Subsequent work sharpened rather than settled this question: whole-MFGM supplementation was replicated in piglets to weaning age and in a human infant randomized trial (both again associational); in vitro digestion-fermentation experiments showed digested whole MFGM itself shifts ileal/cecal microbiota and raises acetate and butyrate; suckling-rat-pup supplementation and Caco-2 (a human intestinal epithelial cell line) studies showed whole MFGM tightening the barrier via phosphoinositide 3-kinase/Akt/mechanistic target of rapamycin (PI3K/Akt/mTOR) and mitogen-activated protein kinase (MAPK) signaling — the cell-line arm demonstrating this route with no microbiota present, while the in vivo rat arm used conventionally colonized animals; and a maternal-supplementation study in growth-restricted mice used fecal microbiota transplant, single-strain gavage, and a SCFA cocktail to prove microbiota-to-SCFA mediation for placental outcomes. Reviews in 2025-2026 still state that the effects of specific MFGM components on infant outcomes are unclear and that mechanisms remain insufficiently characterized. The open question is therefore a causal decomposition of an established associational phenotype.

Problem Statement

In the neonatal (suckling) intestine, as studied in the day-1-to-21 piglet model of Wu et al. (2021): (1) identify which molecular component(s) of bovine MFGM — for example gangliosides or other sphingolipids, MFG-E8/lactadherin, butyrophilin, fatty-acid-binding proteins, or defined glycoprotein/lipid moieties — causally drive the enrichment of SCFA-producing taxa and the upregulation of intestinal barrier genes and barrier function; and (2) determine whether the barrier improvement is causally mediated by the chain taxon enrichment -> increased luminal SCFA -> barrier-gene upregulation, or whether MFGM instead acts directly on the epithelium, as suggested by microbiota-independent in vitro signaling evidence. Durability of the effects beyond day 21, dose and administration-window optimization, and generalization to other breeds, species, or human neonates are acknowledged follow-up questions, not parts of this problem's completion boundary.

References

  1. Yujun Wu, Xiangyu Zhang, Dandan Han, Yu Pi, Shiyu Tao, Shiyi Zhang, Shilan Wang, Junying Zhao, Lijun Chen, Junjun Wang (2021), "Early life administration of milk fat globule membrane promoted SCFA-producing bacteria colonization, intestinal barriers and growth performance of neonatal piglets", Animal Nutrition 7(2):346-355, DOI 10.1016/j.aninu.2020.07.012, https://doi.org/10.1016/j.aninu.2020.07.012
  2. Zonghan Zhou, Bin Liu, Jun Shen, Caihong Yan, Guang Yang, Yu Zhang, Junying Zhao, Lijun Chen (2025), "Milk fat globule membrane supplementation in formula modulates the gut microbiome and metabolic status of piglets and normalizes intestinal development", Frontiers in Nutrition 12:1632519, DOI 10.3389/fnut.2025.1632519, https://doi.org/10.3389/fnut.2025.1632519
  3. Chloe Christensen, Car Reen Kok, Cheryl L. Harris, Nancy Moore, Jennifer L. Wampler, Weihong Zhuang, Steven S. Wu, Robert Hutkins, Jacques Izard, Jennifer M. Auchtung (2024), "Microbiota, metabolic profiles and immune biomarkers in infants receiving formula with added bovine milk fat globule membrane: a randomized, controlled trial", Frontiers in Nutrition 11:1465174, DOI 10.3389/fnut.2024.1465174, https://doi.org/10.3389/fnut.2024.1465174
  4. Caroline Thum, Wayne Young, Carlos A. Montoya, Nicole C. Roy, Warren C. McNabb (2020), "In vitro Fermentation of Digested Milk Fat Globule Membrane From Ruminant Milk Modulates Piglet Ileal and Caecal Microbiota", Frontiers in Nutrition 7:91, DOI 10.3389/fnut.2020.00091, https://doi.org/10.3389/fnut.2020.00091
  5. Rulan Jiang, Xiaogu Du, Lauren Brink, Bo Lönnerdal (2022), "The role of orally ingested milk fat globule membrane on intestinal barrier functions evaluated with a suckling rat pup supplementation model and a human enterocyte model", The Journal of Nutritional Biochemistry 108:109084, DOI 10.1016/j.jnutbio.2022.109084, https://doi.org/10.1016/j.jnutbio.2022.109084
  6. Simone Zuffa, Christophe Lay, Elizabeth A. Wimborne, Arabella Hornung Rodriguez, Yi Wu, Franklin L. Nobrega, Nana Bartke, Anita C. S. Hokken-Koelega, Jan Knol, Guus Roeselers, Jonathan R. Swann (2025), "Milk phospholipid-coated lipid droplets modulate the infant gut microbiota and metabolome influencing weight gain", Microbiome 13:120, DOI 10.1186/s40168-025-02106-w, https://doi.org/10.1186/s40168-025-02106-w
  7. Cuiping Feng, Yujun Wu, Xiangyu Zhang, Shuxian Wang, Junjun Wang, Huixia Yang (2025), "Maternal milk fat globule membrane enriched gut L. murinus and circulating SCFAs to improve placental efficiency and fetal development in intrauterine growth restricted mice model", Gut Microbes 17(1):2449095, DOI 10.1080/19490976.2024.2449095, https://doi.org/10.1080/19490976.2024.2449095
  8. Emine Kocyigit, Elif Çelik, Özge Cemali, Oya Berkay Karaca, Bence Raposa, Duygu Ağagündüz (2026), "Milk fat globule membrane in early-life nutrition: composition, production, and biological effects on infant immune maturation, intestinal development, neurocognitive function, and growth", Frontiers in Nutrition 13:1851487, DOI 10.3389/fnut.2026.1851487, https://doi.org/10.3389/fnut.2026.1851487
  9. Ying Wang, Junrui Wu, Henan Zhang, Xujin Yang, Ruixia Gu, Yumeng Liu, Rina Wu (2025, published online 2024), "Comprehensive review of milk fat globule membrane proteins across mammals and lactation periods in health and disease", Critical Reviews in Food Science and Nutrition 65(23):4435-4456, DOI 10.1080/10408398.2024.2387763, https://doi.org/10.1080/10408398.2024.2387763
  10. Jiayi Zhao, Xuemin Wang, Sufang Duan, Ignatius Man-Yau Szeto, Jian He, Lu Liu, Hui Zhang, Tian Zhang, Xiaodong Li, Xiuxiu Zhang (2026), "Advancing Infant Nutrition: Strategies for Humanizing Infant Formula through Milk Fat Globule Membrane Enrichment", Journal of Agricultural and Food Chemistry 74(16):12625-12641, DOI 10.1021/acs.jafc.5c16836, https://doi.org/10.1021/acs.jafc.5c16836